Offer was a 29% increase to Kite's closing price on Friday.......

  1. 365 Posts.
    lightbulb Created with Sketch. 30
    Offer was a 29% increase to Kite's closing price on Friday....
    I've read that this is a new class of drug but to be used in the field on oncology and will be used with other immunotherapies.
    Hoping that this is a good sign for Cavatak and VLA and there is still a huge appetite for cancer therapies!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.